Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
Monday at 6 on WRAL: WRAL investigates why some veterinarians face minor consequences for fatal errors!
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
ALUR
)
0.7541
-0.0059 (-0.78%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ALUR
< Previous
1
2
Next >
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
October 23, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss
October 09, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
October 04, 2024
Penny stocks are a risky but potentially rewarding opportunity for investors willing to take on their uncertainty; these stocks may stand out from the pack.
Via
MarketBeat
Topics
Bankruptcy
Exposures
Financial
Legal
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
October 01, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Receives Continued Listing Standards Notice from NYSE
September 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
September 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors
September 03, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
August 28, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial
August 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Receives Continued Listing Standards Notice from NYSE
August 15, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update
August 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024
July 16, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement
June 28, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Launch of Offering of Common Stock and Warrants
June 26, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
June 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
June 11, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
June 05, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s
May 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in Two Upcoming Investor Conferences in June 2024
May 29, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss
May 15, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
May 02, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Announces Preliminary First Quarter 2024 Results
April 30, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
April 17, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Expands Virtual Care Suite to the United States
April 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
March 21, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 13, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
March 12, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
March 04, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
February 20, 2024
From
Allurion Technologies, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.